Reuters Health Report

Click to View in Browser 09/15/2014 Exclusive: Two Apple medical trials shed light on how HealthKit will work SAN FRANCISCO (Reuters) - Two prominent U.S. hospitals are preparing to launch trials with diabetics and chronic disease patients using Apple Inc's HealthKit, offering a glimpse of how the iPhone maker's ambitious take on healthcare will work in practice. Gilead signs hepatitis C pact to cut drug cost for poor NEW DELHI/MUMBAI (Reuters) - U.S. drugmaker Gilead Sciences Inc GILD.O has licensed its hepatitis C drug Sovaldi to seven India-based drugmakers that will sell far cheaper versions of the $1,000-a-pill medicine in 91 developing nations. Liberia president sacks 10 officials told to return to fight Ebola MONROVIA (Reuters) - Liberian President Ellen Johnson Sirleaf has sacked 10 senior officials because they failed to heed a warning to return from overseas travel to help the government's fight against an Ebola epidemic that has killed at least 1,100 Liberians. Disease threatens as Kashmir flood waters turn fetid SRINAGAR (Reuters) - Indian emergency workers on Monday battled to prevent waterborne diseases like cholera from spreading as fetid water swilled around the Kashmir valley more than a week after the worst flooding in more than a century. To make the most of a workout, experts say set the proper pace NEW YORK (Reuters) - Whether the goal is to finish a marathon, polish a tennis game or make the most of that hour at the gym, fitness experts say pacing can spell the difference between success and stagnation. Avanir's drug reduces Alzheimer's related agitation in trial (Reuters) - Avanir Pharmaceuticals Inc said its drug was more effective in reducing agitation associated with Alzheimer's, compared with a placebo, sending the company's shares up 55 percent to an over eight-year high. Shire eating disorder drug gets U.S. priority review LONDON (Reuters) - Shire's hyperactivity drug Vyvanse will get a priority review in the United States as a potential treatment for binge eating disorder, showing a willingness by U.S. regulators to consider novel ways to fight eating problems. Malaysia to send 20 million medical gloves to fight Ebola KUALA LUMPUR (Reuters) - Malaysia will send more than 20 million medical rubber gloves to five African nations battling the deadly Ebola virus, addressing a crucial shortage faced by overwhelmed health workers, the country's Prime Minister Najib Razak announced on Monday. Obama to detail plans on Ebola offensive on Tuesday: WSJ (Reuters) - U.S. President Barack Obama is expected to detail on Tuesday a plan to boost his country's involvement in mitigating the Ebola outbreak in West Africa, the Wall Street Journal reported on Sunday. Roche starts late-stage trial for eye drug lampalizumab ZURICH (Reuters) - Swiss drugmaker Roche said on Monday it had started late-stage trials for its experimental drug lampalizumab as a treatment for a serious eye disease. Related Video Wireless charging technology comes to Formula-E racing Bacteria-treated honey cures wounds and offers antibiotic resistance hope The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend